EN
JP
MCRF
About MCRF
Chairman’s Message
History
Successive Directors
Organization Chart
Disclosure
Products
Message from the Director
Laboratories
Office of Director General
Laboratory of Oncology
Laboratory of Microbiology
Laboratory of Microbiology Osada Unit
Laboratory of Microbial Carcinogenesis
Laboratory of Structural Biology
Numazu Branch
Section of Animal Resources
Laboratory of Chemistry
Laboratory of Molecular Structure Analysis
Department of Intellectual Property and Public Relations
Projects
CPZEN-45
CR compounds (Enhancer of NMJ)
Intervenolin
Publications
Compounds
Hamao Umezawa Memorial Museum Meguro (HUM)
Pamphlet
Access/Contact Us
MCRF
About MCRF
Chairman’s Message
History
Successive Directors
Organization Chart
Disclosure
Products
Message from the Director
Laboratories
Office of Director General
Laboratory of Oncology
Laboratory of Microbiology
Laboratory of Microbiology Osada Unit
Laboratory of Microbial Carcinogenesis
Laboratory of Structural Biology
Numazu Branch
Section of Animal Resources
Laboratory of Chemistry
Laboratory of Molecular Structure Analysis
Department of Intellectual Property and Public Relations
Projects
CPZEN-45
CR compounds (Enhancer of NMJ)
Intervenolin
Publications
Compounds
Hamao Umezawa Memorial Museum Meguro (HUM)
Pamphlet
Access/Contact Us
▲
Home
»
History
» 1975
1975
April 30, 2024
Dibekacin was marketed as an antimicrobial antibiotic.
